Saubi N, Andrés C, Prats-Méndez I, González-Sánche. Expansion of influenza A(H1N1)pdm09 NA:S247N viruses with reduced susceptibility to oseltamivir, Catalonia, Spain, and in Europe, July to October 2025. Euro Surveill. 2025 Dec;30(48). Abstract
submitted by kickingbird at 48 minute(s) ago from Euro Surveill. 2025 Dec;30(48)
Between July and October 2025, among the total 117 influenza A(H1N1)pdm09 strains characterised in Catalonia, 20% to 100% per week were carrying the NA:S247N substitution. The mutation, conferring reduced ... Harrell TL, Alvarez-Narvaez S, Porto-Fett ACS, Vin. Inactivation of avian influenza virus in yogurt made from raw milk. Food Microbiol. 2026 Apr;135:104975. Abstract
submitted by kickingbird at 48 minute(s) ago from Food Microbiol. 2026 Apr;135:104975
In March 2024, highly pathogenic avian influenza (HPAIV) H5N1 was first detected in U.S. dairy cattle and has since spread to herds across at least 17 states. Infected cows typically present with mastitis, ... Matyszewska D, Kapu?cińska M, Fontaine P. Elucidating the nature of the interactions of oseltamivir with the 2D model of influenza A virus lipid envelope. Colloids Surf B Biointerfaces. 2025 Nov 29;259:115. Abstract
submitted by kickingbird at 50 minute(s) ago from Colloids Surf B Biointerfaces. 2025 Nov 29;259:115
This study investigates the molecular interactions of the antiviral agent oseltamivir phosphate (OSL) with a two-dimensional (2D) Langmuir monolayer model of the influenza A (AH1N1) virus lipid envelope. ... Reeves C, Miura SST, Chappell AR, Banaag A, Coles. Trends in influenza vaccination uptake in a universally insured population in the united states, 2017-2023. Vaccine. 2025 Dec 3;71:128052. Abstract
submitted by kickingbird at 50 minute(s) ago from Vaccine. 2025 Dec 3;71:128052
Background: Annual vaccination against seasonal influenza is recommended for all persons ages ≥6 months in the U.S., as it is effective in reducing influenza-related illness and death. However, data show ... Qian Zhang, etc.,al. Autoantibodies neutralizing type I IFNs in a fatal case of H5N1 avian influenza. J Exp Med 2 March 2026; 223 (3): e20251962. Abstract
submitted by kickingbird at 55 minute(s) ago from J Exp Med 2 March 2026; 223 (3): e20251962
Avian influenza A virus (IAV) H5N1 is an emerging threat of human pandemic. We describe a 71-year-old man who died of H5N1 pneumonia in Louisiana and whose blood contained autoantibodies neutralizing type ... | |
- 
